ID: ALA5288204

Max Phase: Preclinical

Molecular Formula: C31H30O11

Molecular Weight: 578.57

Associated Items:

Representations

Canonical SMILES:  COc1cc([C@@H]2Oc3cc(/C=C/c4cc(OC(C)=O)cc(OC(C)=O)c4)ccc3O[C@H]2CO)cc(OC)c1OC(C)=O

Standard InChI:  InChI=1S/C31H30O11/c1-17(33)38-23-10-21(11-24(15-23)39-18(2)34)7-6-20-8-9-25-26(12-20)42-30(29(16-32)41-25)22-13-27(36-4)31(40-19(3)35)28(14-22)37-5/h6-15,29-30,32H,16H2,1-5H3/b7-6+/t29-,30-/m0/s1

Standard InChI Key:  ZCYSLRSIRIIKST-QAVHIYSBSA-N

Associated Targets(Human)

HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 578.57Molecular Weight (Monoisotopic): 578.1788AlogP: 4.52#Rotatable Bonds: 9
Polar Surface Area: 136.05Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 3.49CX LogD: 3.49
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.22Np Likeness Score: 0.96

References

1. Yao L, Cai W, Chen S, Wang A, Wang X, Zhao C, Shou C, Jia Y..  (2023)  Design, syntheses and biological evaluation of natural product aiphanol derivatives and analogues: Discovery of potent anticancer agents.,  90  [PMID:37182611] [10.1016/j.bmcl.2023.129326]

Source